SUTTI, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 969
NA - Nord America 687
AS - Asia 241
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.903
Nazione #
US - Stati Uniti d'America 678
IE - Irlanda 314
DE - Germania 164
IT - Italia 154
SE - Svezia 144
UA - Ucraina 85
HK - Hong Kong 58
CN - Cina 57
FI - Finlandia 46
IN - India 46
SG - Singapore 43
FR - Francia 26
VN - Vietnam 18
BE - Belgio 15
TR - Turchia 12
CA - Canada 9
CZ - Repubblica Ceca 6
NL - Olanda 6
GB - Regno Unito 4
IR - Iran 4
NG - Nigeria 4
JP - Giappone 2
PL - Polonia 2
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.903
Città #
Dublin 305
Jacksonville 158
Dearborn 82
Chandler 59
Hong Kong 58
Wilmington 42
Lawrence 33
Princeton 33
Piemonte 27
Singapore 27
Turin 26
Ann Arbor 22
Novara 22
Bremen 21
Beijing 20
Grafing 20
Strasbourg 20
Dong Ket 18
Brussels 15
Ashburn 14
Monmouth Junction 13
San Mateo 13
Andover 12
Helsinki 12
Milan 11
Kocaeli 10
Odalengo Grande 8
Mülheim 7
Toronto 7
Woodbridge 7
Kunming 6
Leawood 6
Nanjing 6
Berlin 5
Brno 5
Amsterdam 4
Bulandshahr 4
Cassano Magnago 4
Fairfield 4
Norwalk 4
Hefei 3
Mumbai 3
Nanchang 3
Rome 3
Vercelli 3
Augusta 2
Bologna 2
Cincinnati 2
Des Moines 2
Fuzhou 2
Guangzhou 2
Houston 2
Karabağlar 2
New York 2
Padova 2
Seattle 2
Winnipeg 2
Zanjan 2
Aix-en-Provence 1
Altavilla Monferrato 1
Ardabil 1
Baotou 1
Barcelona 1
Boardman 1
Brugherio 1
Cambridge 1
Casale Monferrato 1
Castagnito 1
Changchun 1
Chengdu 1
Cicciano 1
Clearwater 1
Düsseldorf 1
Elk Grove Village 1
Fremont 1
Garden City 1
Hangzhou 1
Hebei 1
Jiaxing 1
Jinan 1
Lahore 1
Langfang 1
Munich 1
Nagpur 1
Ningbo 1
Prague 1
Redwood City 1
Riva Presso Chieri 1
Secaucus 1
Senden 1
Shenyang 1
Shimosakunobe 1
Slough 1
Stockholm 1
Trino 1
Wuhan 1
Xian 1
Totale 1.250
Nome #
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice 91
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH) 76
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 75
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis 73
Adaptive immunity: an emerging player in the progression of NAFLD 72
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation 70
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury 69
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 69
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update 65
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 62
Is there a role for adaptive immunity in nonalcoholic steatohepatitis? 61
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein 58
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. 55
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 54
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 53
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 53
CYP2E1 autoantibodies in liver diseases 49
Notch signaling and progenitor/ductular reaction in steatohepatitis. 49
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 47
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts 45
Conformational anti-cytochrome P4502E1 auto-antibodies contributes to necro-inflammatory injury in chronic hepatitis C 44
Immune response against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers 44
Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry 43
NF-kB1 deficiency stimulates the progression of nonalcoholic steatohepatitis (NASH) in mice by promoting NKT-mediated responses 43
Liver inflammation and regeneration in drug-induced liver injury: Sex matters! 43
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 42
Interplay between oxidative stress and steatosis in the progression of Hepatitis C 41
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 40
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 39
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 38
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 36
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease 35
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma 33
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 31
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 29
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 27
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 27
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 18
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 16
Inflammatory processes involved in NASH-related hepatocellular carcinoma 14
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 13
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses 8
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 7
From MASLD to HCC: What's in the middle? 5
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 4
Totale 1.966
Categoria #
all - tutte 10.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.887


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020358 0 0 26 8 48 58 70 22 37 58 30 1
2020/2021217 27 0 28 4 22 8 27 4 34 13 28 22
2021/2022312 10 19 17 10 17 31 35 7 19 24 49 74
2022/2023690 75 31 39 14 49 66 31 21 316 2 33 13
2023/2024242 18 21 13 3 35 7 50 5 9 5 43 33
2024/202516 8 8 0 0 0 0 0 0 0 0 0 0
Totale 1.966